Post-thaw dimethyl sulfoxide reduction in autologous peripheral blood progenitor cell suspensions
The dimethyl sulfoxide removal process and total process recoveries revealed considerable individual variability. To minimize the risk of prolonged engraftment or non-engraftment, it is important to apply this process only to high-risk patients.
Authors
- Miroslava Jandová (ORCID: https://orcid.org/0000-0001-5432-5458)
- Dana Čížková (ORCID: https://orcid.org/0000-0003-3428-3304)
- Jakub Radocha (ORCID: https://orcid.org/0000-0002-5384-8238)
- Miriam Lánská (ORCID: https://orcid.org/0000-0002-8453-1153)
- Aleš Bezrouk (ORCID: https://orcid.org/0000-0002-2397-3847)
- Pavel Měřička (ORCID: https://orcid.org/0000-0002-8408-3645)
- Jiří Gregor
Institutions
- Charles University (CZ)
- University Hospital Hradec Králové (CZ)
Publication Details
- Journal
- Hematology Transfusion and Cell Therapy
- Published
- 2025-08-25
- DOI
- https://doi.org/10.1016/j.htct.2025.103965
- Primary Topic
- RNA Interference and Gene Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00